RJ Reynolds Denied Retrial for Vaping Patent Infringement Case

Jan.16.2023
RJ Reynolds Denied Retrial for Vaping Patent Infringement Case
RJ Reynolds Vapor Co. denied new trial for $95M payment to Altria over Vuse Alto vape pod patent infringement.

RJ Reynolds Vapor Co. has been denied a request to have their September loss reevaluated after being ordered to pay $95 million in damages to Altria Group for violating three vape pod patents with their Vuse Alto electronic cigarettes.


According to reports, Judge N. Carlton Tilley Jr. stated in an opinion released on Thursday in the U.S. District Court for the Middle District of North Carolina that "the jury's disagreement with Reynolds' perspective does not mean the trial was unfair.


Tilley refused the motion made by Reynolds, a subsidiary of BAT, to either retry or reduce the compensation awarded to Altria's customer service company by the jury on September 7th.


In its request for a retrial, Reynolds Vaper argues that "Altria improperly injected provocative evidence regarding allegations of patent infringement against Reynolds in other cases, depriving Reynolds of a fair trial. The erroneous evidence ruling also harmed Reynolds' defense. These errors, taken independently and under the cumulative error doctrine, affected the verdict and thus require a complete retrial.


Altria stated that "this was a fair trial. There is no reason for a retrial, and we are pleased that the jury correctly determined that Reynolds Vapor Company infringed on some of our patents.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Ministry of Health (Minzdrav) has expressed support for a full ban on vapes and “nalivayka” alcohol outlets, calling it an effective measure to curb harmful habits and improve public health.
Oct.17 by 2FIRSTS.ai
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York Attorney General Letitia James has filed a petition seeking to permanently shut down two smoke shops and ban their owners from the vape industry for repeatedly selling illegal flavored vapes to minors and operating without valid licenses. The nearly 50-page complaint names Eysa Sharhan and Ahmed Mozeb and their stores — Pop-In Smoke & Vape LLC, Pufftopia LLC, and Royalty Tobacco LLC — accusing them of a “persistent pattern of illegal activity.”
Oct.24 by 2FIRSTS.ai
Product | VOZOL Launches Two SLEEK-Series Devices Compatible with Mesh and Ceramic Coils
Product | VOZOL Launches Two SLEEK-Series Devices Compatible with Mesh and Ceramic Coils
VOZOL expands its SLEEK line with the SLEEK VISION e-cigarette, which uses the same series pods and supports both mesh and ceramic coils. SLEEK VISION features a boxier design with a 0.99-inch display for battery level and mode, and upgrades the battery to 900 mAh (vs. 600 mAh on SLEEK).
Nov.11 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
NZ Government Eyes Sale of Smokeless Tobacco; Critics Warn of “Backslide”
NZ Government Eyes Sale of Smokeless Tobacco; Critics Warn of “Backslide”
Associate Health Minister Casey Costello faced renewed scrutiny in Parliament’s health select committee over her handling of tobacco-related policy and alleged ties to the tobacco industry. The government is considering allowing smokeless nicotine products such as snus and nicotine pouches, provided they meet safety and youth-access regulations.
Dec.05 by 2FIRSTS.ai
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian Duma considers comprehensive regulations to address widespread e-cigarette use among youth, including potential sales bans and flavor restrictions.
Oct.20 by 2FIRSTS.ai